Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca: FDA Extends Vandetanib NDA Review Timeline To April 7
AstraZeneca: FDA Extends Vandetanib NDA Review Timeline To April 7
AstraZeneca: FDA Extends Vandetanib NDA Review Timeline To April 7
Submitted by
admin
on January 7, 2011 - 10:07am
Source:
WSJ Online
News Tags:
FDA
NDA
vandetanib
AstraZeneca
Headline:
AstraZeneca: FDA Extends Vandetanib NDA Review Timeline To April 7
Do Not Allow Advertisers to Use My Personal information
